Natera Inc (NTRA)
103.25
-4.07 -3.79%
NASDAQ
Apr 14, 12:09
USD
Natera Net Income (Quarterly):
-76.41M for Dec. 31, 2020View 4,000+ financial data types
Browse...
View Full Chart
Net Income (Quarterly) Chart
Export Data
Save Image
Print Image
For advanced charting, view our full-featured
Fundamental Chart
Historical Net Income (Quarterly) Data
View and export this data going back to 2014.
Start your Free Trial
Export Data
Date Range:
| Data for this Date Range | |
|---|---|
| Dec. 31, 2020 | -76.41M |
| Sept. 30, 2020 | -58.32M |
| June 30, 2020 | -59.64M |
| March 31, 2020 | -35.37M |
| Dec. 31, 2019 | -35.18M |
| Sept. 30, 2019 | -23.14M |
| June 30, 2019 | -32.42M |
| March 31, 2019 | -34.09M |
| Dec. 31, 2018 | -31.84M |
| Sept. 30, 2018 | -29.62M |
| June 30, 2018 | -33.82M |
| March 31, 2018 | -32.87M |
| Dec. 31, 2017 | -47.22M |
| Sept. 30, 2017 | -27.86M |
| June 30, 2017 | -29.07M |
| March 31, 2017 | -33.48M |
| Dec. 31, 2016 | -42.47M |
| Sept. 30, 2016 | -26.02M |
| June 30, 2016 | -23.16M |
| March 31, 2016 | -8.685M |
| Dec. 31, 2015 | -22.96M |
| Sept. 30, 2015 | -17.63M |
| June 30, 2015 | -19.68M |
| March 31, 2015 | -10.00M |
| Dec. 31, 2014 | 1.254M |
| Sept. 30, 2014 | 3.724M |
| June 30, 2014 | -0.514M |
| March 31, 2014 | -9.616M |
There is no data for the selected date range.
An error occurred. Please try again by refreshing your browser or contact us with details of your problem.
Advertisement
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Benchmarks
| Exact Sciences Corp | -436.81M |
| Illumina Inc | 257.00M |
| Lantheus Holdings Inc | -3.412M |
Net Income (Quarterly) Range, Past 5 Years
| Minimum | -76.41M | Dec 2020 |
| Maximum | -23.14M | Sep 2019 |
| Average | -37.47M |
Net Income (Quarterly) Related Metrics
| Revenue (Quarterly) | 112.38M |
| Total Expenses (Quarterly) | 186.35M |
| EPS Diluted (Quarterly) | -0.91 |
| Enterprise Value | 8.806B |
| Gross Profit Margin (Quarterly) | 46.71% |
| Profit Margin (Quarterly) | -68.00% |
| Earnings Yield | -2.74% |
| Normalized Earnings Yield | -2.689 |
News
Illumina upgraded at Canaccord Genuity with readthrough to other firms on FTC challenge
SA Breaking News 03/31 10:51 ET
SA Breaking News 03/31 10:51 ET
Natera Signs Strategic Collaboration on Prenatal Genetic Testing With Tesis Labs; Shares Rise Early
MT Newswires 03/31 09:49 ET
MT Newswires 03/31 09:49 ET
Natera and Tesis Labs ink strategic collaboration on prenatal genetic testing
SA Breaking News 03/31 09:14 ET
SA Breaking News 03/31 09:14 ET
Natera and Tesis Labs Announce Strategic Collaboration on Prenatal Genetic Testing
PR Newswire 03/31 09:07 ET
PR Newswire 03/31 09:07 ET
Natera's Signatera test granted two FDA Breakthrough Device Designations
SA Breaking News 03/24 09:34 ET
SA Breaking News 03/24 09:34 ET
FDA Grants Two New Breakthrough Device Designations for Natera's Signatera™ MRD Test
PR Newswire 03/24 09:03 ET
PR Newswire 03/24 09:03 ET
Natera Discloses Patient Screening Using Signatera for Bladder Cancer Study
MT Newswires 03/10 11:07 ET
MT Newswires 03/10 11:07 ET
Natera and Genentech initiate late-stage muscle-invasive bladder cancer trial
SA Breaking News 03/10 09:25 ET
SA Breaking News 03/10 09:25 ET
--Analyst Actions: Morgan Stanley Adjusts Price Target on Natera to $140 From $87, Maintains Overweight Rating
MT Newswires 03/01 11:03 ET
MT Newswires 03/01 11:03 ET
Advertisement
